MEETING REGISTRATION Register today for the NLARx Meeting in Boston November 6th - samples, social media, drug return & redistribution, legislator round table, MA gift banMore
In the States IOWA: Director Sharon Treat Presents to Health and Medication Commissions More VERMONT: AG Hearing on Disclosure of Free Samples; links to Testimony More Report on 1st Circuit Hearing Datamining Law More MAINE: Repeal Likely for Data Law More Law Limiting Online Health-Data Gathering Teeters More Lawmakers Seek Fix for Kids Law More RHODE ISLAND: First State with Complete Retail Pharmacy Participation in e-Prescribing More NEVADA: Case Spurs Pharmacies' Fears of Lawsuits Over Drug Abuse More NEW HAMPSHIRE: Federal Court Rejects Generic Firm's Preemption Defense More ALABAMA: Court Rejects $274 Million Verdicts in Drug Cases More Court Gives Upset Victory to Pharma More NEW YORK: Westchester Slowly Lures Biotech Companies More KENTUCKY: AstraZeneca To Pay $14.7M To State More
Prices and Access to Health Care
Drug Company Coupons To Help Patients Buy Drugs May Raise Premiums More Proposed Change To Medicare Prescription Drugs Could Be Costly More
Fraud and Abuse Congresswoman: Deny Pfizer Any Federal Funding More Roche Files $545 Million Suit Against Credit Suisse More Mylan Labs To Pay $121M Over Medicaid Rebates More FDA Takes Too Long To Ban Researchers After Fraud More
Pharmaceuticals and Health Reform How Drug-Industry Lobbyists Won on Health Care More Health Care Lobbyists Spend Big To Win Big More No Surprise: Pharma's D.C. Lobbying Is Up More Health Reform Triggers Analysis of 'Revolving Door,' Spending More Why the Health-Care Bill Could Be Good for Chantix More Senate Finance Bill: Drug Industry Likes It, Unions Don't More
Conflicts of Interest Dartmouth: Lilly Payments Didn't Violate Policy More CME Accreditation Council to Address Industry Bias More New Conflict Rules at Medical Journals More NAMI: AstraZeneca Is A 'Strong, Effective Partner' More NAMI Board Member Consulted For AstraZeneca More Pharma Payments to Mental Health Group: More to Come? More Merck Unveils $3.7M In Doctor Payment Data More Did Your Doctor Get Paid to Give Talks for Merck? More
Patents and Generics Senate Committee OKs Pay-for-Delay Ban More GPhA Applauds Increase in Funding for FDA's Office of Generic Drugs More PhRMA Supports Biologics Bill More Insulin Drugs Could Lose $6.1B to Biosimilars More GPhA Statement on Senate Judiciary Action on Patent Settlements More NEJM: Exclusivity for Biopharmaceuticals Similar to Hatch-Waxman Act More Generics Firms Balk at $460M in Reform Fees More Sanofi Fights Generics Makers Over Taxotere More Novartis Loses Bellwether Zometa Case More Canadian Judge: Zyprexa Is An 'Almost Invention' More
Advertising and Marketing A Fierce Debate Over Free Drug Samples More Tracking Free Drug Samples More Vermont Considers Disclosing Free Prescription Samples More Lilly Does About-Face On Cymbalta Mailings More US Court Imposes Bextra Penalties More Online Pharma Just Got More Treacherous More AstraZeneca Offers Buyouts To Entire Sales Force More Bristol-Myers Cuts The Abilify Sales Force More Sales Managers Gripe About Lousy Training More No Schering-Plough Ice Cream for You, MA VT MN Doctors! More
Pharma Watch Obama Backs Investors' Rights in Merck Case More Pfizer Rejoins Pharma Stampede to India More Buy! Sell! More Wheeling, Dealing from Bristol-Myers CEO More Inside the $7 Billion Swine Flu Vaccine Industry More How Many Jobs Has Pfizer Cut This Year? More
Electronic Records
Health IT Opportunities Abound, Some Studies Question Value More
PBM Watch Cost-Conscious Medco Pits Plavix Against Effient More Critics Question Ethics of Stepped-Up Pharma Data Mining
More Lilly's Promo Deal with CVS Draws Fire More Cigna Will Keep Pharmacy Benefits Unit More
Medicare and Medicaid Medicare Fraud: One Of The Most Profitable Crimes In U.S. More Pharmaceutical Companies to Pay $124M Over Medicaid Fraud Charges More Health Reform Changes Could Increase Medicaid Costs To States More Alabama Court Tosses Verdicts Against Drugmakers More Medicaid Enrollments Jump But States Are Trying To Cut Costs More
Safety and Clinical Trials
FDA Doesn't Act on Post-Marketing Data More FDA Fails to Follow Up On Rapid Drug Approvals More NEJM: Drug Labels Lack Key Information More Will Novartis Be Found Guilty Of Denying Zometa Risks? More Routine Gardasil Vaccination for Boys: Not Recommended More Is Gardasil Linked To Lou Gehrig's Disease? More Study: Bowel Disease Drugs Increase Cancer Risk More FDA Taps Critic As Advisor More
